Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases - 04/02/20
Anticorps monoclonaux anti-cytokines et maladies cardiovasculaires athéro-thrombotiques
Doi : 10.1016/j.acvd.2019.11.001
Hafid Ait-Oufella a, b, ⁎ 
, Peter Libby c, Alain Tedgui a
, Peter Libby c, Alain Tedgui a a Université de Paris, Inserm U970, Paris Cardiovascular Research Center, Paris, France
b Sorbonne Université, Service de Réanimation Médicale, Hôpital Saint-Antoine, AP–HP, Paris, France
c Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America
⁎Corresponding author at: Inserm U970, Paris Cardiovascular Research Center, Université René Descartes Paris 5, 56, rue Leblanc, Paris, France.Inserm U970, Paris Cardiovascular Research Center, Université René Descartes Paris 556, rue LeblancParisFrance
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Keywords : Cytokines, Immunotherapy, Monoclonal antibody, Atherosclerosis
Mots clés : Inflammation, Immunité, Cytokine, Anticorps monoclonal, Athérosclérose
Esquema
© 2019
Elsevier Masson SAS. Reservados todos los derechos.
Vol 113 - N° 1
P. 5-8 - janvier 2020 Regresar al número
Artículo precedente
- Will artificial intelligence change the job of the cardiac imaging specialist?
- Gilles Barone-Rochette
- Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study
- Marie Bretagne, Bénédicte Lebrun-Vignes, Antoine Pariente, Christian M. Shaffer, Gabriel G. Malouf, Pauline Dureau, Camille Potey, Christian Funck-Brentano, Dan M. Roden, Javid J. Moslehi, Joe-Elie Salem
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.